CYTO -MC $6 m--Covid data readout THIS week.. this low floater could explode on positive results Strategic BentrioTM partnering or divestiture process enters decisive phase Partnering or divestiture process for inner ear therapeutics assets ongoing Database about to be locked in acute COVID-19 trial with Bentrio; top-line data expected by early January 2023 https://finance.yahoo.com/news/altamira-therapeutics-provides-end-2022-134700033.html